Abstract
Introduction
Complex interactions between [Ca 2+ ] i (cytosolic [Ca 2+ ]) and ROS (reactive oxygen species) may shape physiological responses and also contribute to cellular dysfunction in pathological states. Elevated ROS are implicated in endothelial dysfunction and any accompanying perturbation of Ca 2+ signalling has important implications for vascular homoeostasis, since [Ca 2+ ] i regulates endothelial release of vasoactive paracrine factors.
We have measured [Ca 2+ ] i and OS (oxidative stress) simultaneously in CPAE (calf pulmonary artery endothelial cells) using the fluorescent probes fura-2 and C-H 2 DCF (carboxy-2 ,7 -dichlorodihydrofluorescein). ATP stimulated a [Ca 2+ ] i increase that was followed a few seconds later by an increase in OS. We have investigated the relationship between these two parameters, and possible sources of ROS.
Methods
Measurements were made on populations of CPAE grown to confluence on glass coverslips and co-loaded with fura-2 and C-H 2 DCF to measure [Ca 2+ ] i and OS respectively: C-H 2 DCF is sensitive to H 2 O 2 . Results are presented as percentage changes (means ± S.E.M. with n cultures): each determination within a culture was made on a minimum of three coverslips. When only two cultures were used the result is reported as ± half of the difference of the results from the two cultures. Data were analysed for significance using twoway ANOVA followed by Dunnett's test. 
Results

Agonist stimulation
ATP (100 µM) induced a biphasic increase in [Ca 2+ ] i accompanied by a rapid increase in OS, which began a few seconds after the initial increase in [Ca 2+ ] i . There was little further increase in OS over the subsequent 10 min ( Figure 1 ). To gauge the relative magnitude of the ATP-induced OS response we exposed cells to 100 µM H 2 O 2 following washout of the ATP. Over 10 min the H 2 O 2 caused a further increase in OS that was 9 ± 1 (n = 5) times larger than the initial increase induced by ATP.
Potentiation of ATP-induced [Ca
2+ ] i and OS responses by H 2 O 2 Exposing CPAE to 5 µM H 2 O 2 for 100 s prior to and during a 10-min exposure to 100 µM ATP enhanced the [Ca 2+ ] i peak by 71 ± 9% and the initial increase in OS by 64 ± 16% (n = 5). Potentiation of both parameters was still observed if the H 2 O 2 was washed out before application of ATP: pre-exposure to 5 µM H 2 O 2 for 100 s, 75 s prior to ATP application, potentiated the ATP-induced [Ca 2+ ] i peak by 65 ± 13% and the initial increase in OS by 75 ± 26% (n = 6). These effects were all very significant (P < 0.001 2+ ] i peak by 75 ± 21% and the initial rise in OS by 124 ± 41% (n = 2, P<0.001). We also investigated the effect of removing Ca 2+ from the extracellular solution: this reduced the ATPinduced [Ca 2+ ] i peak by 53 ± 6%, and the initial OS response by 74 ± 3% (n = 2, P < 0.001 and P < 0.01 respectively). These data imply that the potentiation of ATP-induced OS by pre-exposure to 5 µM H 2 O 2 is mediated via potentiation of the ATP-induced [Ca 2+ ] i peak. ] stimulates mitochondrial metabolism, ATP could be causing an increase in OS via the mitochondria. We investigated the role of mitochondria using two mitochondrial inhibitors, rotenone (10 µM), which inhibits at complex I, and antimycin A (2 µg/ml), which acts at complex III. Both inhibitors were used in conjunction with oligomycin (5 µg/ml) to prevent the ATP synthase from operating in reverse to consume ATP. All three compounds were dissolved in DMSO and added at 1/1000 dilution. Since DMSO has hydroxyl-radicalscavenging activity, controls contained the same concentration of DMSO (i.e. 2 µl/ml).
Possible sources of ROS
Rotenone significantly enhanced the ATP-induced [Ca 2+ ] i response by 42 ± 7% and the initial increase in OS by 90 ± 17% (n = 3, P < 0.01 and P < 0.001). In contrast, antimycin A reduced the [Ca 2+ ] i peak by 37 ± 6% (n = 2, P < 0.01) with no significant effect on the initial OS response. These data implicate mitochondria in the ATP-induced [Ca 2+ ] i and OS responses, but do not provide a simple explanation regarding the relationship between these two parameters and the source(s) of ROS involved. As mentioned above, mitochondria are a potential source of Ca 2+ -stimulated ROS production but the effects of the inhibitors rotentone and antimycin A are equivocal. Rotenone has been reported to both stimulate and block mitochondrial ROS production but the usual effect of antimycin A is stimulation. Our data therefore suggest that mitochondria are involved in modulating ROS production but may not be the direct source. Both inhibitors should limit mitochondrial Ca 2+ uptake in response to raised [Ca 2+ ] i and so might be expected to potentiate the ATP-induced [Ca 2+ ] i response but, again, our data are not consistent with this.
Conclusions
Together these data show how Ca 2+ and ROS may interact to shape cellular responses and provide an interesting base from which to explore these interactions. Further work is required to clarify the precise role of mitochondria in these responses, the involvement of other sources of ROS and the inter-relationship between Ca 2+ signalling and ROS production.
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